Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenging perspectives on the cellular origins of lymphoma
Tim Malcolm, Daniel J. Hodson, Elizabeth Macintyre, et al.
Open Biology (2016) Vol. 6, Iss. 9, pp. 160232-160232
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers
Przemysław Koźmiński, Paweł Krzysztof Halik, Raphael Chesori, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3483-3483
Open Access | Times Cited: 238
Breast implant-associated anaplastic large cell lymphoma: a review
Andres Quesada, L. Jeffrey Medeiros, Mark W. Clemens, et al.
Modern Pathology (2018) Vol. 32, Iss. 2, pp. 166-188
Open Access | Times Cited: 139
The Epidemiology of Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants
Mark Magnusson, Ken Beath, Rodney D. Cooter, et al.
Plastic & Reconstructive Surgery (2019) Vol. 143, Iss. 5, pp. 1285-1292
Closed Access | Times Cited: 134
Insights into the Microbiome of Breast Implants and Periprosthetic Tissue in Breast Implant-Associated Anaplastic Large Cell Lymphoma
Jennifer N. Walker, Blake Hanson, Chloe L. Pinkner, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 89
Pathogens and Carcinogenesis: A Review
Muhammad Hatta, Ezanee Azlina Mohamad Hanif, Siok‐Fong Chin, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 533-533
Open Access | Times Cited: 66
The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies
Jadwiga Filipek-Gorzała, Patrycja Kwiecińska, Agata Szade, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?
Sepehr Seyed Lajevardi, Pratik Rastogi, Daniel Isacson, et al.
JPRAS Open (2022) Vol. 32, pp. 34-42
Open Access | Times Cited: 29
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Suzanne D. Turner, Giorgio Inghirami, Roberto N. Miranda, et al.
American Journal Of Pathology (2019) Vol. 190, Iss. 1, pp. 2-10
Open Access | Times Cited: 45
Breast Implant-Associated Anaplastic Large Cell Lymphoma
P Rastogi, Anand K. Deva, H. Miles Prince
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 516-524
Closed Access | Times Cited: 39
Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors
Aishwarya Iyer, Dylan Hennessey, Robert Gniadecki
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2334-2345
Open Access | Times Cited: 21
Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
Florian Fitzal, Suzanne D. Turner, Lukas Kenner
Open Biology (2019) Vol. 9, Iss. 4
Open Access | Times Cited: 32
Antibody targeting of surface P‐selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition
João L. Pereira, Francisca Ferreira, Nuno R. dos Santos
Hematological Oncology (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 3
The Cellular Origins of Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Implications for Immunogenesis
Suzanne D. Turner
Aesthetic Surgery Journal (2019) Vol. 39, Iss. Supplement_1, pp. S21-S27
Open Access | Times Cited: 29
Tumor mutational landscape is a record of the pre-malignant state
Kirsten Kübler, Rosa Karlić, Nicholas J. Haradhvala, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 23
UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)
Philip Turton, Dima El‐Sharkawi, Iain Lyburn, et al.
Journal of Plastic Reconstructive & Aesthetic Surgery (2020) Vol. 74, Iss. 1, pp. 13-29
Open Access | Times Cited: 22
Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
Auke Beishuizen, Karin Mellgren, Mara Andrés, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 3, pp. e213-e224
Open Access | Times Cited: 7
UK Guidelines on the Diagnosis and Treatment of Breast Implant‐Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group
Philip Turton, Dima El‐Sharkawi, Iain Lyburn, et al.
British Journal of Haematology (2020) Vol. 192, Iss. 3, pp. 444-458
Open Access | Times Cited: 17
UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)
Philip Turton, Dima El‐Sharkawi, Iain Lyburn, et al.
European Journal of Surgical Oncology (2020) Vol. 47, Iss. 2, pp. 199-210
Closed Access | Times Cited: 16
Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient
Yoko Ohishi, Aki Mitsuda, Kozue Ejima, et al.
Breast Cancer (2020) Vol. 27, Iss. 3, pp. 499-504
Open Access | Times Cited: 12
Resistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL
Lucy Hare, G. A. Amos Burke, Suzanne D. Turner
Cancers (2021) Vol. 13, Iss. 23, pp. 6003-6003
Open Access | Times Cited: 11
T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers
Katrin Schoenfeld, Jan Habermann, Philipp Wendel, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200850-200850
Closed Access | Times Cited: 1
177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma
Marion Masitsa Malenge, Sebastian Patzke, Anne Hansen Ree, et al.
Journal of Nuclear Medicine (2020) Vol. 61, Iss. 10, pp. 1468-1475
Open Access | Times Cited: 10
Role of signaling pathways in the interaction between microbial, inflammation and cancer
Armel Hervé Nwabo Kamdje, Richard Simo Tagne, Hetvet Paulain Fogang Dongmo, et al.
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model
Stefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, et al.
Leukemia (2020) Vol. 34, Iss. 12, pp. 3242-3255
Open Access | Times Cited: 7
An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
Suzanne D. Turner
Cancers (2017) Vol. 9, Iss. 10, pp. 141-141
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top